Elevated levels of Tim-3 on T cells from osteosarcoma patients have been associated with poor survival while Tim-3+PD-1+ tumour-specific T cells in melanoma were found to be dysfunctional [18, 32]. This evidence concerns the gene HAVCR2 and osteosarcoma.